H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.5% of adults in Frisco have diagnosed diabetes — 3.5 points below the U.S. 12% figure. Census population 219,587. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Frisco clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Frisco storefront.
Platelet Rich Plasma (PRP) Therapy in Frisco, TX for clinics & physicians. PRP therapy systems with 1-minu… Compliance support & pricing — contact Hawk Medical.
Frisco is a city under 250k (219,587 Census). CDC PLACES (2023, crude) estimates 8.5% of adults in Frisco have diagnosed diabetes — 3.5 points below the U.S. 12% figure. Adult arthritis here is 17.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)CDC PLACES (2023, crude) estimates 8.5% of adults in Frisco have diagnosed diabetes — 3.5 points below the U.S. 12% figure. Adult obesity in Frisco is 30% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 17.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Frisco warehouse or a five-star local review. What you get is platelet rich plasma therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JH, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 8.5% of adults — 3.5 points below the U.S. 12% figure. Obesity is 30%; arthritis is 17.9%. That is place-level BRFSS modeling, not a clinic census and not a Frisco trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Texas. There is no Frisco storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Texas clinician.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Frisco tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Frisco, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Frisco is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Frisco — 3.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Frisco. Useful for joint-program math; still needs a diagnosis and privileging.
No Frisco storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.